Bluestone Current Trials
Oral Cancer Biomarker Study
Do you have oral pre-cancer or cancer?
Seeking volunteers to take part in a study exploring the causes of oral cancer and oral cancer pain
Oral cancer presents a significant health problem. The 5-year survival rate for oral squamous cell carcinoma is 40% and is among the worst of all sites in the body. This survival rate has not improved over the past 40 years. Early detection and treatment profoundly impact survival; however there are currently no genetic markers available to identify pre-cancer and cancer.
The purpose of this study is to find what leads to cancer pain by examining the proteins in blood, saliva, urine, fluid, and tissue produced by oral cancer. This may help doctors to provide very specific therapy for oral cancer and pain. This study will compare the bio-fluids and tissues in oral cancer and oral pre-cancer patients, and healthy volunteers.
You may be eligible to participate in this study if you have been recently diagnosed with a suspicious lesion in your mouth, are at least 18 years of age, not pregnant or lactating, and have never previously been treated for head or neck cancer with chemotherapy and/or radiation.
For patients diagnosed with oral cancer who are scheduled for surgery, this study consists of 3 visits over a period of 3 months.
For patients diagnosed with oral pre-cancer and are scheduled for tissue biopsy, this study consists of 2 visits over a period of 2 months.
This study is also recruiting healthy volunteers who are scheduled for teeth extraction or corrective jaw surgery at the NYU College of Dentistry. For this group of participants, this study consists of 1 visit, which will take place at the same time as your scheduled visit to the dental clinic.
Interested in participating?
If you, a family member, or someone you know is interested in this study, please contact our clinical research coordinator at the Bluestone Center at 212-998-9310. We will get back to you as soon as possible. Confidentiality will be maintained for all applicants and participants.
Number of visits:
1 day to 3 months
Male and Female
18 and over
Improving Brain Health During Breast Cancer Therapy
If you are a postmenopausal woman who was diagnosed with breast cancer, you may qualify for this research study. The purpose of this study is to learn whether Mindfulness-Based Stress Reduction or a Health Enhancement Program improves cognitive function (your ability to concentrate and remember things) for women who take aromatase inhibitors. This study will evaluate cognitive function using a brain imaging technique called Magnetic Resonance Imaging (MRI), cognitive tests, and questionnaires. You will be paid up to $250 for completing the study.
- Have gone through menopause (are postmenopausal)
- Are younger than 80 years of age
- Are diagnosed with stage 0 (DCIS) or stage 1, 2, or 3 breast cancer
- Are taking an aromatase inhibitor or will be starting it soon
- No stage IV (metastatic) breast cancer
- Not claustrophobic (afraid of being in an MRI machine)
- No major psychiatric disorder (schizophrenia, bipolar I disorder); no neurological disorder (Parkinson's Disease, dementia); and no head trauma.
Interested in participating?
If you, a family member, or someone you know is interested in this study, please contact our clinical research coordinator Makeda Brown at 212-998-9202 or email@example.com. We will get back to you as soon as possible. Confidentiality will be maintained for all applicants and participants.
Number of visits: 11
Duration: 6 months
Ages: 18–79 years
Phone number: (212) 998-9310
Status: Closed Recruitment